Monopar Therapeutics Shares Resume Trade Then Again Halted On Circuit Breaker To The Downside, Stock Now Up 542.3%
Portfolio Pulse from Benzinga Newsdesk
Monopar Therapeutics experienced significant stock volatility, with trading resuming and then being halted again due to a circuit breaker. Despite this, the stock is up 542.3%.
October 24, 2024 | 4:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Monopar Therapeutics' stock experienced extreme volatility, with trading resuming and then being halted again due to a circuit breaker. Despite the halts, the stock price surged by 542.3%.
The stock's significant price increase of 542.3% indicates strong upward momentum, despite the trading halts due to circuit breakers. This suggests high investor interest and potential for further price movements.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100